These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 19079435

  • 21. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T, Wells S, Jackson R, Lee AW, Crengle S, Bramley D, Ameratunga S, Pylypchuk R, Broad J, Marshall R, Kerr A.
    N Z Med J; 2010 Feb 19; 123(1309):50-61. PubMed ID: 20186242
    [Abstract] [Full Text] [Related]

  • 22. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
    Owen AJ, Retegan C, Rockell M, Jennings G, Reid CM.
    Clin Exp Pharmacol Physiol; 2009 Jul 19; 36(7):643-7. PubMed ID: 19076166
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K, Kerr AJ, McLachlan A, Gow P, Kumar S, Ly J, Wiltshire C, Robinson E, Dalbeth N.
    N Z Med J; 2008 Nov 07; 121(1285):73-81. PubMed ID: 19079439
    [Abstract] [Full Text] [Related]

  • 24. Challenges for the management of hypertension in low-resource settings.
    Mendis S.
    Ethn Dis; 2003 Nov 07; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [Abstract] [Full Text] [Related]

  • 25. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults.
    Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D.
    J Cardiovasc Pharmacol; 2009 May 07; 53(5):388-400. PubMed ID: 19454899
    [Abstract] [Full Text] [Related]

  • 26. Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study.
    White B, Chamberlain N.
    N Z Med J; 2009 May 22; 122(1295):28-37. PubMed ID: 19648984
    [Abstract] [Full Text] [Related]

  • 27. Acute Predict: a clinician-led cardiovascular disease quality improvement project (Predict-CVD 12).
    Kerr AJ, Looi JL, Garofalo D, Wells S, McLachlan A.
    Heart Lung Circ; 2010 May 22; 19(5-6):378-83. PubMed ID: 20392667
    [Abstract] [Full Text] [Related]

  • 28. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
    Mehta S, Wells S, Riddell T, Kerr A, Pylypchuk R, Marshall R, Ameratunga S, Chan WC, Thornley S, Crengle S, Harrison J, Drury P, Elley CR, Bell F, Jackson R.
    J Prim Health Care; 2011 Jun 01; 3(2):93-101. PubMed ID: 21625656
    [Abstract] [Full Text] [Related]

  • 29. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.
    Rafter N, Connor J, Hall J, Jackson R, Martin I, Parag V, Vander Hoorn S, Rodgers A.
    N Z Med J; 2005 Oct 07; 118(1223):U1676. PubMed ID: 16224500
    [Abstract] [Full Text] [Related]

  • 30. Differences in health-related socioeconomic characteristics among Pacific populations living in Auckland, New Zealand.
    Sundborn G, Metcalf P, Schaaf D, Dyall L, Gentles D, Jackson R.
    N Z Med J; 2006 Jan 27; 119(1228):U1823. PubMed ID: 16462928
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular risk factors levels of Pacific people in a New Zealand multicultural workforce.
    Schaaf D, Scragg R, Metcalf P.
    N Z Med J; 2000 Jan 28; 113(1102):3-5. PubMed ID: 10738491
    [Abstract] [Full Text] [Related]

  • 32. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System.
    Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH.
    Am J Prev Med; 2006 Jan 28; 30(1):74-7. PubMed ID: 16414427
    [Abstract] [Full Text] [Related]

  • 33. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D.
    Pharmacoepidemiol Drug Saf; 2008 May 28; 17(5):485-94. PubMed ID: 18383562
    [Abstract] [Full Text] [Related]

  • 34. Access and society as determinants of ischaemic heart disease in indigenous populations.
    Curtis E, Harwood M, Riddell T, Robson B, Harris R, Mills C, Reid P.
    Heart Lung Circ; 2010 May 28; 19(5-6):316-24. PubMed ID: 20444647
    [Abstract] [Full Text] [Related]

  • 35. Improving organisational systems for diabetes care in Australian Indigenous communities.
    Bailie R, Si D, Dowden M, O'Donoghue L, Connors C, Robinson G, Cunningham J, Weeramanthri T.
    BMC Health Serv Res; 2007 May 06; 7():67. PubMed ID: 17480239
    [Abstract] [Full Text] [Related]

  • 36. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec 06; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular disease: application of a composite risk index from the Telehealth System in a district community.
    Yip YB, Wong TK, Chung JW, Ko SK, Sit JW, Chan TM.
    Public Health Nurs; 2004 Dec 06; 21(6):524-32. PubMed ID: 15566557
    [Abstract] [Full Text] [Related]

  • 38. [A cross-sectional survey to evaluate the cardiovascular risk profile in subjects referred to the Verona-ASL 20 general practitioners].
    Bastarolo D, Battaggia A, Blengio G, Bustacchini S, Celebrano M, Danti G, Flor L, Girotto S, Joppi R, Lombardo G, Mezzalira L, Mirandola M, Panfilo M, Pescarin G, Ruffo P, Gruppo Collaborativo Progetto Verona.
    Ital Heart J Suppl; 2005 Jun 06; 6(6):382-7. PubMed ID: 16013431
    [Abstract] [Full Text] [Related]

  • 39. Community screening for cardiovascular risk factors and levels of treatment in a rural Māori cohort.
    Faatoese AF, Pitama SG, Gillies TW, Robertson PJ, Huria TM, Tikao-Mason KN, Doughty RN, Whalley GA, Richards AM, Troughton RW, Sheerin IG, Wells JE, Cameron VA.
    Aust N Z J Public Health; 2011 Dec 06; 35(6):517-23. PubMed ID: 22151157
    [Abstract] [Full Text] [Related]

  • 40. A comparative analysis of cardiovascular disease risk profiles of five Pacific ethnic groups assessed in New Zealand primary care practice: PREDICT CVD-13.
    Grey C, Wells S, Riddell T, Pylypchuk R, Marshall R, Drury P, Elley R, Ameratunga S, Gentles D, Erick-Peletiy S, Bell F, Kerr A, Jackson R.
    N Z Med J; 2010 Nov 05; 123(1325):41-52. PubMed ID: 21317960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.